DOJ Charges 193 in $2.75B Healthcare Fraud, Seizes $231M in Assets

Iran "Very Close" to Weapons Grade Uranium [Today's Breaking News]( [GOLD WARNING]( [adv] [Meta must face lawsuit claiming it prefers foreign workers over US citizens]( A U.S. appeals court on Thursday revived a software engineer's proposed class action claiming Meta Platforms refused to hire him because it preferred to give jobs to foreign workers who are paid lower wages. The San Francisco-based 9th U.S. Circuit Court of Appeals in a 2-1 ruling said that a Civil ... [Read More >>]( [Iran "Very Close" to Weapons Grade Uranium [sponsor]]( Iran can produce uranium for a nuke in "just a week," American physicist and nuclear expert David Albright explained. Iran is "galloping ahead" with its nuclear program, the director of the International Atomic Energy Agency said. Thankfully, the U.S. has a new weapon that would make Iran think twice before ever launching one. [Get all the details here ]( [US charges 193 people in $2.75 billion health care fraud bust]( The government seized more than $231 million in cash, luxury vehicles, gold and other assets in the law enforcement action that spanned 32 federal districts. Cases include unlawful distribution of millions of pills of Adderall and $146 million in fraudulent drug addiction treatment schemes, the department sai ... [Read More >>]( [Ex-Wall Street VP: "Something Odd Just Happened" [sponsor]]( The Man Who the Wall Street Journal Named "World's Greatest Investor" Just Bought Shares in This Powerful, Secretive Company. [Learn why, here.]( [US issues fresh sanctions against Iran over nuclear escalations]( The United States on Thursday issued fresh sanctions targeting Iran in response to "continued nuclear escalations," U.S. Secretary of State Antony Blinken said in a statement."Over the past month, Iran has announced steps to further expand its nuclear program in ways that have no credibl ... [Read More >>]( [The NEXT Trillion Dollar Company? [sponsor]]( It just signed a deal to get its tech in Apple's iPhone until 2040! Online commenters are debating if this brand-new company will be the 7th trillion dollar stock. [Details on the controversy here.]( [Biden, Trump's age and fitness in focus in early debate faceoff]( Democratic President Joe Biden and his Republican predecessor, Donald Trump, square off on Thursday at an unusually early debate that will offer voters a side-by-side look at the two oldest candidates ever to seek the country's highest office.The 90-minute televised debate, the first betwee ... [Read More >>]( [The Tiny Tech Disrupting the $28.4B Hospital Infection Epidemic [sponsor]]( Hospital-acquired infections are a silent killer, but one small company's nanotechnology could put an end to this costly crisis. Their proactive approach is turning heads in the healthcare industry. [Learn how this innovative technology could save lives and potentially deliver substantial returns for early investors]( Sponsored Content [do this at 2:59pm TODAY]( [The "Smart Money" Is Ready for July 30th Are You?]( [Revealed: Nvidia's Secret Weapon]( [Be sure that you receive future email from ProTrading Research – please]( our email address]( with your email provider. --------------------------------------------------------------- IMPORTANT NOTICE AND DISCLAIMER Pro Trading Research, LLC ("PTR"), the owner of this website (the "Website"), cannot guarantee the accuracy or completeness of the information contained in any article, email, newsletter, or other publication posted on or viewed in connection with this website (the "Publications"). The author or authors of those Publications are solely responsible for their contents. PTR has not done any research or due diligence into the markets, industries, or companies which may appear or be mentioned in the Publications. PTR will NOT be liable for any loss or damage caused by a reader's reliance on information posted on the Website or contained in the Publications. FOR EDUCATIONAL AND INFORMATIONAL PURPOSES ONLY; NOT INVESTMENT ADVICE. This Website and the Publications are for educational and informational purposes only. This Website and the Publications do not purport to be a complete analysis of any company's financial position. This Website, the Publications or any statements made in the Publications are not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular individual. This Website or the statements made in the Publications should NOT be relied upon for purposes of transacting in any securities posted on the Website or mentioned in the Publications, nor should they be construed as a personalized recommendation to you to buy, sell, or hold any position in any security posted on this Website or mentioned in any Publications. SUBSTANTIAL RISK IN INVESTMENT. Any individual who chooses to invest in any securities including those mentioned in the Publications should do so with caution. Investing or transacting in securities involves substantial risk; you may lose some, all, or possibly more than your original investment. Readers bear responsibility for their own investment research and decisions and should review all investment decisions with a licensed or registered investment professional. NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER Neither PTR nor any of its respective owners or employees are registered or licensed as a securities broker-dealer, broker, an investment advisor, or an investment advisor representative with the U.S. Securities and Exchange Commission (SEC), any state securities regulatory authority, or any self-regulatory organization. To more fully understand our Website, please review our full disclaimer located at: [( DISCLAIMER: ProTrading Research is strictly a research publishing firm and much of the information we publish in email and our various websites are obtained from sources we believe to be reliable. You should know that accuracy can never be guaranteed. We do not design our content to meet your personal situation & you need to know we are absolutely not financial advisors and we never, under any circumstance give our users personalized advice. Every single opinion we express herein are those of the publisher and are subject to change without notice. Published content may become outdated and there is no obligation to update any such information. This communication includes advertising material and PAID ADVERTISEMENTS provided to our customers. Stocks and options trading have large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the stocks and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell stocks or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed in this report. The past performance of any trading system or methodology is not necessarily indicative of future results. All trades, patterns, charts, systems, etc., discussed in this report are for illustrative purposes only and not to be construed as specific advisory recommendations. Information contained in this correspondence is intended for informational purposes only and was obtained from sources believed to be reliable. Information is in no way guaranteed. No guarantee of any kind is implied or possible where projections of future conditions are attempted. Sponsored emails, like this in ProTrading Research or our other publications, contain paid advertisements and don't necessarily endorse or recommend it to you or any investor. Neither the company nor our affiliates bear responsibility or control over the content of the advertisement and the product or service offered. Proceed at your own risk. [Privacy Policy]( If you wish to contact us, please do not reply to this message but instead e-mail us at info@em.protradingresearch.com. Replies to this message may not be read or responded to. We are unable to respond to emails and phone calls requesting personal financial advice. Sponsored emails, like this in ProTrading Research or our other publications, contain paid advertisements and don't necessarily endorse or recommend it to you or any investor. Neither the company nor our affiliates bear responsibility or control over the content of the advertisement and the product or service offered. Proceed at your own risk. If you wish to contact us, please do not reply to this message but instead e-mail us at info@em.protradingresearch.com. Replies to this message may not be read or responded to. We are unable to respond to emails and phone calls requesting personal financial advice. At ProTrading Research, it's our mission to create and provide a community that helps you live a more lucrative and enriched life. When ProTrading Research was established a few years back, we wanted to make the community an inclusive, welcoming table where everyone can come to find investment trends! Over the years, and over 100 thousand combined followers across our social media platforms, we will always aim to get better at what we do every single day! In addition, our primary focus is on our relationship with you. This way every time you decide to visit one of our properties or read one of our relevant articles, you end up getting an idea that takes your investment portfolio to the next level. We particularly appreciate when our following provides feedback via testimonials, reviews, and comments left on our site or social media accounts. Because with that feedback, we can use it to make your next investment or stock purchase even better than the last! Since we put so much effort into the relationship with you, we hope that any time spent with us is exactly the way you hoped it would be. Because by choosing to go with ProTrading Research, it's our promise that we provide a community you will love for years and years to come. Now, as much as we care about helping you make the right investments, we also care about your privacy. At ProTrading Research transparency and the use of data are important and we would like to be as explicit as we can about the use of data collected through our platforms. ProTrading Research is owned and operated by . We're committed to the right of your privacy and strive to provide a safe and secure user experience. Our Privacy Policy explains how we collect, store and use personal information, provided by you on our website. What Information Do We Collect? When you visit our Web site you may provide us with two types of information: personal information you knowingly choose to disclose that is collected on an individual basis and Web site use information collected on an aggregate basis as you and others browse our Web site following all compliance standards. For example, you may need to provide the following information: - Name - Website URL information - Email address - Home and business phone number In addition to providing the foregoing information, if you choose to correspond further with us through email, we may retain the content of your email messages together with your email address and our responses securely within our systems. We provide the same protections for these electronic communications that we employ in the maintenance of information received by mail and telephone. It also explains important information that ensures we won't abuse the information that you provide to us in good faith. By accessing and using our website, you can trust that what you want to be kept private, will be kept private. If at any time, you would like to read our Privacy Policy and get a better understanding of your rights and liabilities under the law. Feel free to visit our site, find the privacy policy in the footer and read it. If there is something you are concerned about or wish to get more clarity on, please let us know by contacting us at info@em.protradingresearch.com. The Privacy Policy also informs you of how to notify us to stop using your personal information. If you wish to view our official policies, please visit our website where you can find the latest information regarding data collection and use. If you end up visiting we are strongly committed to protecting your privacy and providing a safe & high-quality online experience for all of our visitors. We understand that you care about how the information you provide to us is used and shared. We have developed a Privacy Policy to inform you of our policies regarding the collection, use, and disclosure of information we receive from users of our website. ProTradingResearch.com operates the Website. This privacy policy has been created to keep you informed about the steps we take once data is acquired. It is regularly updated to meet the needs of a changing technological environment ensuring its relevancy. Our [Privacy Policy]( along with our [Term & Conditions]( governs your use of this site. By using or by accepting the Terms of Use (via opt-in, checkbox, pop-up, or clicking an email link confirming the same), you agree to be bound by our Terms & Conditions and our Privacy Policy. If you have provided personal, billing, or other voluntarily provided information, you may access, review, and make changes to it via instructions found on the Website or by emailing us at info@em.protradingresearch.com. To manage your receipt of marketing and non-transactional communications, you may unsubscribe by clicking the "unsubscribe" link located on the bottom of any marketing email. By clicking the link you will be taken to a page where you may unsubscribe from future marketing emails. Your change in status may take up to seventy-two hours to be reflected within our system. Emails related to the purchase or delivery of orders are provided automatically – Customers are not able to opt-out of transactional emails. We will try to accommodate any requests related to the management of Personal Information in a timely manner. However, it is not always possible to completely remove or modify information in our databases (for example, if we have a legal obligation to keep it for certain timeframes, for example). If you have any questions, simply reply to this email or visit our website to view our official policies. As an important reminder the ideas and opinions of the writers of the content shared should be taken for informational and entertainment purposes. Independent research is an important part of investing success and due diligence should be practiced. For use of personal information please read below and be advised on the data that we collect and how it will be used in the future. Within our content you will see advertisements that are clearly labeled identifying them as products or services offered by our advertising partners. These products and services are provided by our advertising partners and not by ProTrading Research. ProTrading Research 180 N Stetson Avenue, Ste 3500 | Chicago, IL 60601 [Unsubscribe Here]( Be sure that you receive future email from ProTrading Research – please [whitelist our email address]( with your email provider.